Breaking News
6.8 SPC vs. 300 Blackout: Powering Up the AR Platform
Autism Study By McCullough Foundation Begins New Era of Free Scientific Inquiry
REVOLUTION DAY 8: Libertarians JOIN The Revolution
US Government and Westinghouse $80bn Nuclear Reactor Deal
Top Tech News
Graphene Dream Becomes a Reality as Miracle Material Enters Production for Better Chips, Batteries
Virtual Fencing May Allow Thousands More Cattle to Be Ranched on Land Rather Than in Barns
Prominent Personalities Sign Letter Seeking Ban On 'Development Of Superintelligence'
Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
Retina e-paper promises screens 'visually indistinguishable from reality'
Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
Future of Satellite of Direct to Cellphone
Amazon goes nuclear with new modular reactor plant
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them
China Innovates: Transforming Sand into Paper
Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19
The First Randomized Controlled Trial on Vitamin D and COVID-19
The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.
The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.